within Pharmacolibrary.Drugs.S_SensoryOrgans.S01E_AntiglaucomaPreparationsAndMiotics.S01EB58_AceclidineCombinations;
model AceclidineCombinations 
   extends Pharmacolibrary.Drugs.ATC.S.S01EB58;

  annotation(Documentation(
    info ="<html><body><p>Aceclidine is a parasympathomimetic miotic agent primarily used in ophthalmology for the treatment of glaucoma and other ocular conditions to reduce intraocular pressure. It acts as a muscarinic receptor agonist. Currently, aceclidine is not widely used and is not approved in many countries.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic parameters for aceclidine in combination products with ATC code S01EB58 were identified in the literature. The following PK parameters are estimated for a typical adult using topical ocular administration.</p><h4>References</h4><ol><li><p>Matera, MG, et al., &amp; Rossi, F (1998). Bioavailability of timolol and aceclidine after ocular instillation in the rabbit. <i>Research communications in molecular pathology and pharmacology</i> 100(1) 35â€“42. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9644717/&quot;>https://pubmed.ncbi.nlm.nih.gov/9644717</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end AceclidineCombinations;
